ERC Starting Grant · 2020
Pathogen-responsive hydrogels release antimicrobial vesicles for local infection treatment
The rise of bacterial resistance against antibiotic drugs is becoming the leading cause for morbidity and mortality worldwide. In Europe alone, up to 33,000 people die each year from infections with resistant bacteria. Current antibiotic therapy often suffers from low selectivity, adverse side effects in other organs and impaired ability to overcome bacterial barriers. These problems limit the efficacy of our antibiotic arsenal. Local and effective eradication of bacterial infections is of utmost importance to avert the formation of new resistances. My research centres on naturally derived vesicles. All living cells and microorganisms produce these nanoparticles and equip them with unique…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.